Moderna, Inc. (MRNA)
52.84
+2.16
(+4.26%)
USD |
NASDAQ |
Apr 14, 16:00
52.90
+0.06
(+0.11%)
After-Hours: 20:00
Moderna Free Cash Flow : -2.075B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Biogen, Inc. | 1.969B |
| Gilead Sciences, Inc. | 9.456B |
| Johnson & Johnson | 19.70B |
| Arbutus Biopharma Corp. | -39.72M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 930.00M |
| Cash from Investing (Quarterly) | -48.00M |
| Cash from Financing (Quarterly) | 581.00M |
| Free Cash Flow Per Share (Quarterly) | 2.273 |
| Free Cash Flow to Equity (Quarterly) | 320.00M |
| Free Cash Flow to Firm (Quarterly) | 899.27M |
| Free Cash Flow Yield | -10.10% |